
Baricitinib Impurity 88 NEW
Price | Get Latest Price | ||
Package | 5mg | 20mg | 50mg |
Min. Order: | 1mg |
Supply Ability: | 10000 |
Update Time: | 2025-05-27 |
Product Details
Product Name: Baricitinib Impurity 88 | Min. Order: 1mg |
Purity: >95% HPLC | Supply Ability: 10000 |
Release date: 2025/05/27 | |
Molecular Formula:: C16H15N7O4S | Mol. Weight:: 401.4 |
Appearance: : Yellow soild |
Product Catalog: | B026088 |
CAS No.: | |
Product Name: | Baricitinib Impurity 88 |
Purity: | >95% HPLC |
Synonyms: | 2-(3-(4-(5,6-dioxo-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-1-(ethylsulfonyl)azetidin-3-yl)acetonitrile |
Molecular Formula: | C16H15N7O4S |
Mol. Weight: | 401.4 |
Appearance: | Yellow soild |
Storage: | 2-8°C Refrigerator |
Contact: | WhatsAPP: +86 17320513646 E-mail: anna@molcoo.com |
Note: | We can also customize related analogues and modified peptides including HPLC, MS, 1H-NMR, MS, HPLC, IR, UV, COA, MSDS. This product is intended for laboratory use only! |
Background: | Baricitinib is a Janus kinase (JAK) inhibitor used in the treatment of various inflammatory and autoimmune diseases, such as rheumatoid arthritis. The specific impurity you mentioned, 2 - (3 - (4 - (5,6 - dioxo - 6,7 - dihydro - 5H - pyrrolo[2,3 - d]pyrimidin - 4 - yl) - 1H - pyrazol - 1 - yl) - 1 - (ethylsulfonyl)azetidin - 3 - yl)acetonitrile, may be formed during the synthesis process of baricitinib. Impurities in drugs can potentially affect the safety, efficacy, and quality of the drug product. Understanding and controlling these impurities is crucial for ensuring the quality and safety of baricitinib - based medications. |
Company Profile Introduction
1. Drug standards and drug impurity reference substances: provide more than 20,000 kinds of spot impurity reference substances, with sufficient supply and same-day delivery. We have a professional R&D team and comprehensive quality control testing to ensure product quality and reliability.
2. Customized synthesis of impurities and new molecules: Quickly respond to the customized needs of CDE impurities, stably supply impurities that have established quality standards, and provide customized synthesis services for new compounds in the research and development of innovative drugs.
3. Preparation and separation of unknown impurities: With a professional impurity preparation and separation technical team and SFC preparation and separation instruments, we can solve the problems of impurity preparation in complex projects.
4. Process development of new drug intermediates: provide the supply of new drugs and new molecular impurities, process optimization services, as well as the screening and impurity analysis of commercialization routes.
5. Peptide synthesis: Provide customized peptide synthesis services, and cover all kinds of degradation impurities and process impurities generated in the research and development of peptide drugs. At the same time, it provides comprehensive structural confirmation data and customized testing services.
You may like
Recommended supplier
Product name | Price | Suppliers | Update time | |
---|---|---|---|---|
$0.00/5mg |
VIP1Y
|
Guangzhou Tosun Pharmaceutical Ltd
|
2025-01-24 | |
$0.00/10mg |
VIP2Y
|
ShenZhen H&D Pharmaceutical Technology Co., LTD
|
2025-03-31 | |
$2.00/1kg |
VIP2Y
|
Jinan Million Pharmaceutical Co., Ltd
|
2023-08-11 |
INQUIRY